Reported 2,725,000 shares, down 820,000 (23.1%) from the prior quarter.
Reported value 64.4%; share count -23.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 4044000 |
| 2023-09-30 | 3959298 |
| 2023-12-31 | 2721258 |
| 2024-03-31 | 2879329 |
| 2024-06-30 | 3522519 |
| 2024-09-30 | 3705692 |
| 2024-12-31 | 4061654 |
| 2025-03-31 | 4716157 |
| 2025-06-30 | 4360350 |
| 2025-09-30 | 7166750 |
| 2025-12-31 | 8432000 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -2,720,000 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 2,720,000 | -5,000 (-0.2%) | 1.11% | $8,432,000 | 2026-02-17 | |
| Q3 2025 | Reduced | 2,725,000 | -820,000 (-23.1%) | 1.01% | $7,166,750 | 2025-11-14 | |
| Q2 2025 | Reduced | 3,545,000 | -742,415 (-17.3%) | 0.88% | $4,360,350 | 2025-08-14 | |
| Q1 2025 | Reduced | 4,287,415 | -202,585 (-4.5%) | 1.05% | $4,716,157 | 2025-05-15 | |
| Q4 2024 | Added | 4,490,000 | +824,990 (22.5%) | 0.71% | $4,061,654 | 2025-02-14 | |
| Q3 2024 | Reduced | 3,665,010 | -244,990 (-6.3%) | 0.62% | $3,705,692 | 2024-11-14 | |
| Q2 2024 | Added | 3,910,000 | +1,469,891 (60.2%) | 0.8% | $3,522,519 | 2024-08-14 | |
| Q1 2024 | Reduced | 2,440,109 | -542,091 (-18.2%) | 0.63% | $2,879,329 | 2024-05-15 | |
| Q4 2023 | Reduced | 2,982,200 | -1,772,000 (-37.3%) | 0.72% | $2,721,258 | 2024-02-14 | |
| Q3 2023 | Added | 4,754,200 | +1,384,200 (41.1%) | 1.29% | $3,959,298 | 2023-11-15 | |
| Q2 2023 | New | 3,370,000 | +3,370,000 (0.0%) | 0.97% | $4,044,000 | 2023-08-14 |
Who else reported the position
180 managers reported GOSSAMER BIO INC COM (DE) for Q3 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| NEA Management Company LLC | Unchanged | 18,093,034 | 0 | 2.61% | $47,584,679 | 13 qtrs |
| Octagon Capital Advisors LP | Reduced | 17,050,000 | -1,300,000 | 6.8% | $44,841,500 | 20 qtrs |
| BlackRock Inc | Added | 13,846,054 | +1,703,458 | < 0.01% | $36,415,120 | 5 qtrs |
| VANGUARD GROUP INC | Added | 12,009,773 | +598,981 | < 0.01% | $31,585,704 | 27 qtrs |
| ARCH Venture Management LLC | Unchanged | 8,055,916 | 0 | 4.3% | $21,187,059 | 9 qtrs |
| Samsara BioCapital LLC | Unchanged | 6,130,268 | 0 | 2.1% | $16,122,605 | 9 qtrs |
| Palo Alto Investors LP | Reduced | 5,464,349 | -274,664 | 2.66% | $14,371,238 | 22 qtrs |
| Siren L L C | Unchanged | 5,208,968 | 0 | 0.54% | $13,699,586 | 5 qtrs |
| 683 Capital Management LLC | Reduced | 5,059,200 | -1,280,800 | 0.7% | $13,305,696 | 9 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 5,012,969 | -2,133,053 | 0.02% | $13,181,000 | 12 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2025
- Filed
- November 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 2,725,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.